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Background: The genetic architecture of ADHD is complex, with rare and common variants involved. Common
genetic variants (as indexed by a composite risk score) associated with clinical ADHD significantly predict ADHD and
autistic-like behavioural traits in children from the general population, suggesting that ADHD lies at the extreme of
normal trait variation. ADHD and other neurodevelopmental disorders share neurocognitive difficulties in several
domains (e.g. impaired cognitive ability and executive functions). We hypothesised that ADHD composite genetic risk
scores derived from clinical ADHD cases would also contribute to variation in neurocognitive abilities in the general
population.Methods: Children (N = 6,832) from a UK population cohort, the Avon Longitudinal Study of Parents and
Children (ALSPAC), underwent neurocognitive testing. Parent-reported measures of their children’s ADHD and
autistic-like traits were used to construct a behavioural latent variable of ‘neurodevelopmental traits’. Composite
genetic risk scores for ADHD were calculated for ALSPAC children based on findings from an independent ADHD
case–control genome-wide association study. Structural equation modelling was used to assess associations between
ADHD composite genetic risk scores and IQ, working memory, inhibitory control and facial emotion recognition, as
well as the latent ‘neurodevelopmental trait’ measure. Results: The results confirmed that neurocognitive and
neurodevelopmental traits are correlated in children in the general population. Composite genetic risk scores for
ADHD were independently associated with lower IQ (b = .05, p < .001) and working memory performance
(b = .034, p = .013), even after accounting for the relationship with latent neurodevelopmental behavioural trait
scores. No associations were found between composite genetic risk scores and inhibitory control or emotion
recognition (p > .05). Conclusions: These findings suggest that common genetic variants relevant to clinically
diagnosed ADHD have pleiotropic effects on neurocognitive traits as well as behavioural dimensions in the general
population. This further suggests that the well-recognised association between cognition and neurodevelopmental
behavioural traits is underpinned at a biological level. Keywords: ALSPAC, ADHD, genetics, cognition.
Introduction
Attention-deficit hyperactivity disorder (ADHD) is a
highly heritable neurodevelopmental disorder (Fara-
one et al., 2005). It is clear that the genetic archi-
tecture of ADHD is complex, with common and rare
variants involved (Neale et al., 2010; Stergiakouli
et al., 2012; Williams et al., 2010; Yang et al., 2013).
ADHD is strongly associated with autism spectrum
disorder (ASD) and other neurodevelopmental disor-
ders (Thapar, Cooper, Eyre, & Langley, 2013). Twin
studies also demonstrate significant co-heritability
across neurodevelopmental disorders and traits,
including ADHD and ASD (Lichtenstein, Carlstr€om,
Rastam, Gillberg, & Anckars€ater, 2010; Ronald,
Simonoff, Kuntsi, Asherson, & Plomin, 2008). These
findings suggest that genetic risk variants for ADHD
are likely to contribute to multiple neurodevelop-
mental behavioural traits and disorders.
Indeed, there is an increased burden of rare copy
number variants (CNVs) in ADHD, which overlap
more than expected by chance with regions impli-
cated in other neurodevelopmental conditions, such
as ASD or schizophrenia (Lionel et al., 2011; Martin
et al., 2014a; Williams et al., 2010, 2012). However,
such CNVs are rare and so it is likely that other types
of genetic variants also contribute to this overlap.
There is evidence that commonly occurring genetic
variants play a role in risk for ADHD. First, when
considered in aggregate (i.e. as a composite risk
score), common risk alleles defined from a clinical
ADHD case-control genome-wide association study
(GWAS) are higher in an independent set of ADHD
cases than controls (Hamshere et al., 2013a). Sec-
ond, common additive variants collectively show
moderate heritability for ADHD when estimated
using genome-wide complex trait analysis (GCTA)
software (Lee et al., 2013; Yang et al., 2013).
The evidence is mixed so far in terms of possible
overlap of common genetic risk variants across
ADHD and other disorders. One study found that
common risk alleles relevant to schizophrenia are
enriched in ADHD cases when compared with
controls (Hamshere et al., 2013b). However, two
recent cross-disorder studies from the Psychiatric
Genomics Consortium, found no overlap of commonConflict of interest statement: No conflicts declared.
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variants across clinical samples of ADHD and ASD or
schizophrenia (Lee et al., 2013; Smoller et al., 2013).
Nevertheless, these analyses are inconclusive as the
ADHD and ASD samples were substantially smaller
than those available for the adult disorders, which
did show significant overlap of risk alleles. Further-
more, in a general population cohort, composite
genetic risk for ADHD, using scores derived from a
clinical discovery sample, predict ADHD and
social-communication/autistic-like behavioural
traits (Martin, Hamshere, Stergiakouli, O’Donovan,
& Thapar, 2014b). On the whole, these results
suggest that common genetic variants may show
some pleiotropic effects on different neurodevelop-
mental behavioural traits, both in clinical cases and
in the general population.
Neurocognitive problems
Children affected by ADHDoften havemultiple, prom-
inent neurocognitive difficulties. These affect a range
of domains, notably involving global cognitive ability
(Frazier,Demaree,&Youngstrom,2004)andexecutive
functioning, such as response inhibition and working
memory (Willcutt, Sonuga-Barke, Nigg, & Sergeant,
2008), as well as aspects of social cognition, such as
facial emotion recognition (Collin, Bindra, Raju, Gill-
berg, & Minnis, 2013; Uekermann et al., 2010). Like
ADHD, these neurocognitive domains are heritable
(Ando, Ono, & Wright, 2001; Deary, Johnson, &
Houlihan, 2009; Rommelse, Geurts, Franke, Bu-
itelaar, & Hartman, 2011). There is also evidence
suggesting that difficulties in these domains share
familial and genetic risks with ADHD (Bidwell, Will-
cutt,DeFries,&Pennington,2007;Kuntsi et al., 2004;
Schachar et al., 2005). Moreover, difficulties in these
domains are not unique to ADHD, but rather these
deficits are also strongly associated with other neuro-
developmental disorders, including ASD and schizo-
phrenia (Fett et al., 2011;Matson&Shoemaker, 2009;
Uljarevic & Hamilton, 2012;Willcutt et al., 2008). It is
not yet known whether common genetic variants
relevant to clinical ADHD also contribute to neurocog-
nitive abilities, typically assessed through task-based
performance, in the general population.
The aim of the current study was to examine
whether a common genetic composite risk score,
based on case-control GWAS findings for clinical
ADHD, influences general cognitive ability, executive
functioning and social cognition in children from the
general population. It was hypothesised that com-
posite genetic risk scores would predict lower
neurocognitive abilities in these domains. A second-
ary aim was to test whether observed associations
were independent of associations between neurocog-
nitive abilities and neurodevelopmental behavioural
traits, specifically, parent-reported ADHD and
social-communication behavioural traits in this
sample (Martin et al., 2014b).
Methods
Target population sample – ALSPAC
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a large, well-characterised longitudinal dataset
(Boyd et al., 2013; Fraser et al., 2013). ALSPAC originally
recruited N = 14,541 pregnant women resident in Avon,
England, with expected delivery dates of April 1, 1991, to
December 31, 1992. Of these pregnancies, N = 13,988 chil-
dren were alive at age 1 year. An additional eligible 713
children were enrolled after age 7, resulting in a total sample
of N = 14,701 of children. The study website (http://www.bris.
ac.uk/alspac/researchers/data-access/data-dictionary/) con-
tains details of all available data. Ethical approval for the study
was obtained from the ALSPAC Ethics and Law Committee and
the Local Research Ethics Committees. Full data (phenotypic
and genotypic) were available for up to N = 6,832 children,
depending on the outcome variables.
Neurocognitive task measures
ALSPAC families were invited to attend a ‘Focus’ clinic when
the children were aged approximately 8.5 years old, where they
underwent neuropsychological testing. A short form of the
WISC-III assessment was employed to obtain an estimate of
full scale IQ (Wechsler, 1992). In addition to this, the WISC-III
Digit Span task was administered to obtain a measure of verbal
working memory. Cognitive inhibitory control was assessed
using the Opposite Worlds task from the Tests of Everyday
Attention for Children battery (Robertson, Ward, Ridgeway, &
Nimmo-Smith, 1996). The mean time taken to complete the
control condition (Same Worlds trials) was subtracted from the
mean time for the experimental condition (Opposite Worlds
trials) and the resulting score was transformed (1/square root
of score). Facial emotion recognition was assessed using a
computerised version of the faces subtest of the Diagnostic
Analysis of Nonverbal Accuracy (DANVA) (Nowicki & Duke,
1994). The task comprised four emotion types (happy, sad,
angry or fearful) shown at high (easy condition) and low (hard
condition) intensities. The total number of errors made on the
12 low emotional intensity faces (normally distributed) was
used for analysis.
In addition to these four measures (IQ, working memory,
cognitive inhibitory control and facial emotion recognition), the
Counting Span Task, another measure of working memory,
was administered at age ~10.5 years. The measure used was a
computer-generated normally distributed ‘global score’, corre-
sponding to the number of correct trials.
Parent-reported measures of ADHD and
social-communication
Measures of ADHD and social-communication assessed at a
similar time to the neurocognitive measures were included in
analyses as these were previously found to be associated
with ADHD composite genetic risk scores (Martin et al.,
2014b). Total ADHD inattentive and hyperactive-impulsive
traits were calculated by summing the relevant items
from the parent Development and Well-Being Assessment
(DAWBA) administered at approximately 7.5 years old (Good-
man, Ford, Richards, Gatward, & Meltzer, 2008). Social-
communication traits were assessed using the Social and
Communication Disorders Checklist (SCDC) at the same
age (Skuse, Mandy, & Scourfield, 2005), as well as
the pragmatic language scales of the Children’s Communi-
cation Checklist (CCC) at approximately 9.5 years (Bishop,
1998). CCC pragmatic language scores were transformed
(ln 9 + 1) and reversed so that higher scores meant more
difficulties.
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Genetic data
A total of 9,912 ALSPAC children were genotyped. After quality
control (QC), genome-wide data for 500,527 single nucleotide
polymorphisms (SNPs) were available for N = 8,229 of the
children, of whom N = 4,213 (51.2%) were male. Details of QC
procedures have been reported previously (Martin et al.,
2014b).
The results of a published GWAS of British and Irish
children with a diagnosis of ADHD (N = 727) and population
controls (N = 5,081) were utilised as the primary discovery
sample. The QC procedures, ascertainment of these samples
and GWAS results have been described in detail previously
(Stergiakouli et al., 2012). This GWAS was based on 502,702
SNPs after QC. Composite risk scores were calculated for each
ALSPAC child using PLINK (Purcell et al., 2007), based on the
results of the above GWAS discovery sample, as described
previously (Martin et al., 2014b). In brief, SNPs in approximate
linkage equilibrium in the ALSPAC data were identified using
PLINK, with SNPs exceeding a threshold of R2 ≥ .2 excluded. As
in our previous work, the primary tests of our hypotheses were
based on risk alleles enriched (at p < .5) in ADHD cases in the
discovery GWAS. This list of risk alleles was used to calculate a
composite risk score for each individual in ALSPAC, corre-
sponding to the mean number of score alleles (weighted by
odds ratio) across the set of SNPs, using the PLINK command
(–score). Composite risk scores were also calculated at a variety
of other p-value thresholds to test the sensitivity of observed
results. The composite genetic scores were standardised using
z-score transformations.
Data analysis
Pearson correlations were used to examine associations
between performance on the neurocognitive measures and
parent-reported ADHD and social-communication traits.
Females and males were compared in terms of neurocognitive
phenotypes, using Student’s t-test. The neurocognitive mea-
sures were standardised using z-score transformations. Analy-
seswere performedusing Stata version 13.0 (StataCorp., 2013).
The main analysis was conducted in several steps. First,
multivariate linear regression analyses were used to test for
associations between composite genetic risk scores and each of
the neurocognitive measures, after controlling for the effect of
gender.
Next, given previous work showing that ADHD composite
genetic risk scores predict both parent-reported ADHD and
social-communication traits (Martin et al., 2014b), confirma-
tory factor analysis was used to derive a ‘neurodevelopmental
difficulties’ latent variable. This variable was based on par-
ent-reported ADHD inattentive and hyperactive-impulsive
traits, as well as CCC pragmatic language and SCDC social
cognition scores. Goodness of fit of the latent variable model
was assessed using the root mean square error of approxima-
tion (RMSEA), comparative fit index (CFI) and Tucker-Lewis fit
index (TLI) statistics. Good model fit was indicated by an
RMSEA fit statistic ≤ .06 and CFI and TLI statistics > .95 (Hu &
Bentler, 1999). Multiple indices were used as this provides a
more comprehensive evaluation of model fit.
As a final step, structural equationmodelling (SEM)wasused
to test a model of ADHD composite genetic risk score effects on
neurocognitive measures and the latent variable of neurodevel-
opmental difficulties. SEM has the potential to simultaneously
estimate the relationships of multiple manifest/observed and
latent predictor and outcome variables. For the purpose of this
study, the SEM models combine regression, path and factor
analyses. Given that neurodevelopmental and neurocognitive
measures are related, modelling the association of composite
genetic risk scores with both measures simultaneously can be
used to determine the unique effect of composite genetic scores
on each of these measures. On figures, manifest variables are
represented by squares, latent variables are represented by
circles, singledirectionarrows indicate regressionpaths,double
direction arrows indicate correlations and numbers indicate
regression/correlation coefficients.
Model goodness of fit was assessed as above. The model
estimator used was ‘MLR’, which is robust to non-normality
and provides full information maximum likelihood estimation
with robust standard errors, using all available data for each
model. SEM was performed using Mplus version 7 (Muthen &
Muthen, 1998). All p-values presented are two-tailed. Given
the non-independence of the four neurocognitive measures
and the structured analytic approach, all results are inter-
preted using a significance threshold of p < .05.
Secondary analyses
Analyses were re-run using 10 EIGENSTRAT principal com-
ponents as covariates to account for possible population
ancestry effects. Analyses were also re-run using composite
risk scores calculated in ALSPAC using alternative p-value
selection thresholds.
Replication analyses
Where significant associations were observed, comparable
analyses were run to determine whether the same associations
in the ALSPAC sample could be replicated using composite risk
scores derived from an independent ADHD discovery sample
(using the same analytical method). This second sample
consisted of the published international Psychiatric Genomics
Consortium (PGC) meta-analysis of ADHD case-control GWAS
(Neale et al., 2010) based on four individual studies. It
consisted of 2,064 trios, 896 cases and 2,455 control individ-
uals and 1,206,461 SNPs after QC.
Results
Phenotypic relationships
Table 1 shows Pearson correlation coefficients for
associations between each neurocognitive measure
and ADHD and social-communication trait scores.
All correlations are significant (p < .001), although
coefficients are low to modest, with the highest
correlation being between IQ and the Digit Span
subtest (r = .39).
Table 1 Correlations between neurocognitive and neurodevel-
opmental measures
IQ
Working
memory
Inhibitory
control
Emotion
recognition
Working
memory
.39
Inhibitory
control
.21 .11
Emotion
recognition
.16 .11 .09
ADHD
hyperactive-
impulsive
.16 .13 .07 .09
ADHD inattentive .21 .19 .12 .09
Social cognition .14 .11 .05 .10
Pragmatic
language
.25 .18 .06 .08
All significant at p < .001.
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Males had lower working memory scores (age
8.5 years: t = 6.79, p < .001; age 10.5 years:
t = 2.30, p = .022) and made more emotion recog-
nition errors (t = 4.46, p < .001) than females. They
did not differ from females in terms of inhibitory
control (t = 1.78, p = .075) or IQ (t = .68, p = .50).
Neurocognition and composite genetic scores
After adjusting for gender, ADHD composite genetic
risk scores, derived from the primary discovery sam-
ple (Stergiakouli et al., 2012), predicted lower IQ
(b = .05, p < .001, R2 = .0027) and lower working
memory abilities (b = .034, p = .013, R2 = .0011).
There were no associations with inhibitory control
(b = .006, p = .66) or emotion recognition (b = .004,
p = .76).
The confirmatory factor analytic/latent variable
model of inattentive, hyperactive-impulsive,
social-cognitive and pragmatic language traits
showed moderately good fit (RMSEA = .053,
CFI = .994, TLI = .982; see Figure S1). SEM testing
was used to simultaneously model the associations
of ADHD composite genetic risk scores with the
latent neurodevelopmental trait variable and the
neurocognitive measures, as well as the correlation
between these measures. The SEM results were
consistent with the linear regression analyses, with
higher ADHD composite genetic risk scores predict-
ing lower IQ (b = .052, p < .001, R2 = .003) and
working memory (b = .034, p = .008, R2 = .001)
and no associations with inhibitory control and
facial emotion recognition (p > .05). Model diagrams
are displayed in Figure 1 and Figure S2. Model fit
was satisfactory for all models (see figure captions).
ADHD composite risk scores also predicted lower
working memory abilities (b = .042, p = .002,
R2 = .0018), as assessed using the global score of
the Counting Span Task at the approximate age of
10.5 years. SEM with the neurodevelopmental diffi-
culties latent variable showed a consistent result
(b = .042, p = .002, R2 = .002); see Figure 2.
Secondary analyses
SEM including both IQ and working memory (at age
8.5 years) as correlated outcomes showed that these
outcomes are independently predicted by ADHD
composite genetic risk scores (see Figure S3).
To test the sensitivity of the results with regards to
inclusion of the latent neurodevelopmental variable,
analyses were re-run with ADHD inattentive and
hyperactive-impulsive traits as manifest outcome
variables and omitting the measures of social-
communication. The pattern of results was the same
as before (see Figure S4).
To look at the effect of population stratification,
analyses were co-varied for 10 EIGENSTRAT covari-
ates. This did not affect the results (see Table S1).
The pattern of results was consistent across different
selection thresholds for generating the composite
genetic risk scores (see Figure S5).
Gender was entered as a covariate for all models.
When analyses were instead stratified by gender, the
association between composite genetic risk scores
and IQ was seen separately for both females
(b = .060, p = .0011, R2 = .0038) and males
(b = .045, p = .023, R2 = .0019), whereas the asso-
ciation with working memory at age 8 was only seen
in females (b = .041, p = .031, R2 = .0017) and not
males (b = .027, p = .16, R2 = .0007).
Replication analyses
Composite risk scores derived from the published
replication discovery data (Neale et al., 2010) showed
an association with lower IQ (b = .030, p = .028,
R2 = .0009), but no association withworkingmemory
at either time point (age 8: b = .018, p = .18; age 10:
b = .015, p = .27). SEM testing showed the same
pattern of results (see Figure 3 and Figure S6).
Discussion
This study finds that common genetic risk variants
that predict risk of clinical ADHD diagnosis and that
were previously found to predict parent-reported
ADHD and social-communication behavioural traits
in the general population (Martin et al., 2014b) are
also associated with lower IQ and working memory
in children from the general population. ADHD
composite genetic risk scores were not found to be
associated with inhibitory control or facial emotion
recognition measures. The associations of ADHD
composite genetic risk scores with IQ and working
memory persisted even after taking into account
associations with neurodevelopmental (ADHD and
social-communication) behavioural traits, using
structural equation modelling, and were robust to
sensitivity testing. These results suggest that com-
mon genetic risk variants relevant to a clinical
diagnosis of ADHD may have effects on multiple
neurocognitive abilities, as well as behavioural traits
in the general population.
The association between ADHD composite genetic
risk scores and working memory was also observed
with a different measure of working memory,
assessed at a later time point. Composite genetic
risk scores based on changing the allele selection
thresholds were also consistently associated with
both IQ and working memory problems at both time
points. The observed association between ADHD
composite genetic risk scores and IQ was further
robust to replication using a second ADHD discovery
dataset (Neale et al., 2010). However, no association
was observed with either measure of working mem-
ory using composite genetic risk scores derived from
the replication discovery data.
This inconsistency of results using the primary
and replication discovery samples could theoretically
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be attributable to potential differences in clinical or
cognitive profiles between the two datasets (Neale
et al., 2010; Stergiakouli et al., 2012). Alternatively,
subtle differences in ancestry may have contributed
to this discrepancy; the primary discovery sample is
more homogenous and ancestrally more similar to
the target ALSPAC sample than the replication
sample, which was a meta-analysis of multiple
samples. Furthermore, the effects that are observed
are very small (R2 ≤ .0034), albeit they are
comparable to those reported in other studies using
the composite genetic risk score method (Anney
et al., 2012; Hamshere et al., 2013a). Small effect
sizes in this type of study are affected by the
relatively small ADHD GWAS discovery sample sizes,
which have low power to detect susceptibility vari-
ants and thus a poor signal-to-noise ratio, making it
unlikely that the current analysis reflects the true
magnitude of the observed associations (Neale et al.,
2010; Stergiakouli et al., 2012). However, the possi-
bility of a false positive finding cannot be ruled out
without additional replication.
As associations were observed only between ADHD
composite genetic risk scores and IQ and working
memory, but not inhibitory control and emotion
recognition abilities, this suggests the possibility of
(A)
(B)
Figure 1 Associations between composite genetic scores with IQ and working memory. **p < .01, ***p < .001; ND: Neurodevelopmental.
(A) Association of composite genetic scores with IQ (N = 6,832); RMSEA = .053, CFI = .974, TLI = .952. (B) Association of composite genetic
scores with working memory (N = 6,827); RMSEA = .045, CFI = .981, TLI = .966
Figure 2 Association between composite genetic scores with working memory at age 10 years. *p < .05, **p < .01, ***p < .001; ND:
Neurodevelopmental. N = 6,847; RMSEA = .045, CFI = .981, TLI = .966
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specific pleiotropic effects. Interestingly, in children
with ADHD, increasing levels of ASD traits are
associated with lower IQ and more severe working
memory difficulties, although not with attentional
flexibility (Cooper, Martin, Langley, Hamshere, &
Thapar, 2014). This previous study suggests that IQ
and working memory problems may be a marker of
additional neurodevelopmental problems or pheno-
typic complexity in the context of an ADHD diagno-
sis. The current study builds on this finding by
suggesting that genetic risks for ADHD are relevant
to lower IQ and working memory abilities in the
general population, in addition to parent-reported
neurodevelopmental behavioural traits (Martin
et al., 2014b). The results are also comparable to a
study of ADHD probands and their siblings, which
found that the genetic factors contributing to low IQ
are unlikely to explain the shared genetic effects of
ADHD with other cognitive phenotypes such as
performance on a go/no-go task (Wood et al., 2011).
Although the correlations between the neurocogni-
tive abilities and ADHD and social-communication
traits were modest, the results from this general
population sample are in keeping with findings from
clinical studies showing lower IQ, working memory,
inhibitory control and emotion recognition abilities in
children with ADHD and other neurodevelopmental
problems, suchasASD (Frazier et al., 2004;Matson&
Shoemaker, 2009; Uekermann et al., 2010; Uljarevic
& Hamilton, 2012; Willcutt et al., 2008). Further-
more, the magnitude of these results is consistent
with the known heterogeneity of neurocognitive abil-
ities in children with ADHD; despite group differ-
ences, when compared with controls, not all children
with ADHD or other neurodevelopmental problems
experience these additional deficits (Nigg, Willcutt,
Doyle, & Sonuga-Barke, 2005; Willcutt et al., 2008).
The results also show that on a population level,
there are average differences in neurocognitive abil-
ities between males and females, with males showing
poorer working memory and emotion recognition
abilities. It is well known that neurodevelopmental
problems are also more common in males than
females (Keen & Ward, 2004; Lichtenstein et al.,
2010). However, the reasons for these gender group
differences are unclear. One theory suggests that
males have a lower liability threshold than females,
which leads to them developing problems when
exposed to a lower burden of risk variants. This
theory has some support in terms of clinical ADHD
and ASD phenotypes (Hamshere et al., 2013a; Rhee
& Waldman, 2004; Robinson, Lichtenstein, Anck-
ars€ater, Happe, & Ronald, 2013) but it is unknown
whether it could also explain observed gender differ-
ences in neurocognitive domains. Further work
is needed to explore the nature of these gender
(A)
(B)
Figure 3 Associations between composite genetic risk scores (based on replication discovery sample) with IQ and working memory.
**p < .01, ***p < .001; ND: Neurodevelopmental. (A) Association of composite genetic scores with IQ (N = 6,832); RMSEA = .053,
CFI = .974, TLI = .953. (B) Association of composite genetic scores with working memory (N = 6,827); RMSEA = .045, CFI = .982, TLI = .967
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differences in neurocognitive abilities, particularly in
the context of neurodevelopmental problems.
Given the longitudinal nature of the ALSPAC
sample and the associated nonrandom attrition
(Wolke et al., 2009), missing data were handled by
using the ‘full information maximum likelihood’
(FIML) estimator in the SEM analyses. This approach
maximised the use of all available data, in contrast
to using pairwise deletion. A sensitivity test showed
that restricting the SEM analyses to children who
had complete data for each analysis, using listwise
deletion, decreased the effect sizes, but otherwise did
not alter the pattern of observed results (see Figure
S7).
One additional limitation of this study is that the
neurocognitive tasks assessed in the ALSPAC sample
around ages 7–9 years (i.e. when the ADHD and
social-communication measures were assessed),
were not specifically selected for previously showing
familial effects with ADHD. Previous family and twin
studies have suggested that there are shared genetic
effects between ADHD and measures of IQ, working
memory (as assessed by the WISC Digit Span test),
inhibitory control (assessed using a stop-signal reac-
tion time task) and other cognitive measures not
examined in the current study (Bidwell et al., 2007;
Kuntsi et al., 2004; Schachar et al., 2005). At present
it is not known whether some of the cognitive mea-
sures used in this study (i.e. the Opposite Worlds or
DANVA tasks) share genetic risks with ADHD.
Conclusion
Results from this population study indicate that a
composite score of common genetic risk, previously
found to be associated with a clinical ADHD diagno-
sis, predicts lower general cognitive ability and lower
working memory in children in the general popula-
tion. These genetic variants appear to have pleiotro-
pic effects, predicting the presence of behavioural
traits and neurocognitive performance in children.
These results extend a growing body of literature
highlighting the importance of shared molecular
genetic factors across multiple psychiatric and psy-
chological phenotypes.
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Key points
• Attention-deficit hyperactivity disorder (ADHD) and other neurodevelopmental disorders (e.g. autism
spectrum disorder (ASD) and schizophrenia) are highly heritable and may overlap in genetic risks.
• They are also associated with general cognitive delay and difficulties with executive functions and social
cognition.
• A composite measure of common genetic risk variants relevant to a clinical diagnosis of ADHD has previously
been found to predict traits of ADHD and social-communication difficulties in the general population.
• This study suggests that common genetic variants relevant to ADHD diagnosis may also play a role in normal
variation in IQ and working memory abilities, independent of their effect on ADHD and ASD-like/
social-communication traits in the general population.
© 2014 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
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